Market Overview

Top 4 NYSE Stocks In The Drug Delivery Industry With The Highest Revenue

Related HSP
Earnings Scheduled For July 30, 2014
Why Earnings Season Could Be Great for Hospira (HSP) - Tale of the Tape
Related VRX
UPDATE: Valeant Pharmaceuticals Posts Higher Q2 Profit
Earnings Scheduled For July 31, 2014
Allergan Rebuffs Valeant's Tender Offer (Fox Business)

Below are the top drug delivery stocks on the NYSE in terms of revenue.

The trailing-twelve-month revenue at Hospira (NYSE: HSP) is $4.02 billion. Hospira had $655.90 million in total cash for the latest quarter.

The trailing-twelve-month revenue at Valeant Pharmaceuticals International (NYSE: VRX) is $2.75 billion. Valeant Pharmaceuticals' operating margin for the same period is 23.99%.

The trailing-twelve-month revenue at Elan Corporation plc (NYSE: ELN) is $1.29 billion. Elan's ROE for the same period is 102.84%.

The trailing-twelve-month revenue at K-V Pharmaceutical Company (NYSE: KV-A) is $23.20 million. K-V Pharmaceutical had $50.70 million in total cash for the latest quarter.

Posted-In: Drug Delivery Industry Highest Revenue NYSETrading Ideas

 

Most Popular

Related Articles (ELN + HSP)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters